OTCMKTS:GNGBYGETINGE AB/ADR Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding GETINGE AB/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $18.47 -0.40 (-2.12 %) (As of 04/8/2020 03:18 PM ET) Add Compare Share Today's Range$18.20Now: $18.47▼$18.7750-Day Range$14.99MA: $17.44▼$19.6352-Week Range$11.62Now: $18.47▼$19.63Volume8,277 shsAverage Volume11,264 shsMarket Capitalization$4.69 billionP/E Ratio39.30Dividend Yield0.37%Beta0.97 ProfileAdvanced ChartDividendEarningsHeadlinesSocial Media Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers practice-oriented monitoring systems and disposables; anesthesia, beating heart surgery, and ceiling devices; washer-disinfectors, consumables, and IT-solutions; connected solutions; consumables products; drain products; endoscope reprocessing; endoscopic vessel harvesting systems; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packaging services; intra-aortic balloon counter pulsation therapies; critical care ventilators; modular room systems; operating lights; operating tables and accessories; operating room (OR) furniture; OR integration systems; patient flow management solutions; patient transport solutions; sealing equipment; sterile supply management and traceability solutions; sterilizers; surgical assist systems; surgical perfusion components; loading and distribution trolleys; trays and baskets; and after sales consulting services. The company also provides automated bedding handling equipment, closure processing systems, washers, and isolation and sterile transfer products; professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for GETINGE AB/ADR. Previous Next 2.3 Community Rank Outperform VotesGETINGE AB/ADR has received 111 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGETINGE AB/ADR has received 130 “underperform” votes. (Add your “underperform” vote.)Community SentimentGETINGE AB/ADR has received 53.94% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about GETINGE AB/ADR and other stocks. Vote “Outperform” if you believe GNGBY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GNGBY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipGETINGE AB/ADR is a leading dividend payer. It pays a dividend yield of 0.37%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthGETINGE AB/ADR does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, GETINGE AB/ADR insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.04% of the stock of GETINGE AB/ADR is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of GETINGE AB/ADR is 39.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 12.21.Price to Earnings Ratio vs. SectorThe P/E ratio of GETINGE AB/ADR is 39.30, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.80.Price to Book Value per Share RatioGETINGE AB/ADR has a P/B Ratio of 2.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.79 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNGBY Previous Symbol CUSIPN/A CIKN/A Webhttp://www.getinge.com/ Phone46-1-033-500-00Debt Debt-to-Equity Ratio0.26 Current Ratio0.99 Quick Ratio0.67Price-To-Earnings Trailing P/E Ratio39.30 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.81 billion Price / Sales1.67 Cash Flow$1.60 per share Price / Cash Flow11.51 Book Value$8.15 per share Price / Book2.27Profitability EPS (Most Recent Fiscal Year)N/A Net Income$129.29 million Net Margins4.54% Return on Equity9.20% Return on Assets4.17%Miscellaneous Employees12,000 Outstanding Shares254,152,000Market Cap$4.69 billion Next Earnings Date4/28/2020 (Estimated) OptionableNot Optionable Receive GNGBY News and Ratings via Email Sign-up to receive the latest news and ratings for GNGBY and its competitors with MarketBeat's FREE daily newsletter. OTC:GNGBY Rates by TradingView GETINGE AB/ADR (OTCMKTS:GNGBY) Frequently Asked Questions How has GETINGE AB/ADR's stock been impacted by COVID-19 (Coronavirus)? GETINGE AB/ADR's stock was trading at $16.29 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GNGBY shares have increased by 13.4% and is now trading at $18.47. View which stocks have been mosted impacted by Coronavirus. When is GETINGE AB/ADR's next earnings date? GETINGE AB/ADR is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for GETINGE AB/ADR. How were GETINGE AB/ADR's earnings last quarter? GETINGE AB/ADR (OTCMKTS:GNGBY) released its quarterly earnings results on Friday, January, 31st. The company reported $0.40 earnings per share for the quarter. The company earned $884.45 million during the quarter. GETINGE AB/ADR had a net margin of 4.54% and a return on equity of 9.20%. View GETINGE AB/ADR's earnings history. Has GETINGE AB/ADR been receiving favorable news coverage? News articles about GNGBY stock have trended very negative on Wednesday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. GETINGE AB/ADR earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutGETINGE AB/ADR. Who are some of GETINGE AB/ADR's key competitors? Some companies that are related to GETINGE AB/ADR include SONOVA HLDG AG/ADR (SONVY), Masimo (MASI), Varian Medical Systems (VAR), LivaNova (LIVN), CONMED (CNMD), InMode (INMD), Natus Medical (NTUS), Viewray (VRAY), Zynex (ZYXI), AxoGen (AXGN), TransMedics Group (TMDX), BioLife Solutions (BLFS), Semler Scientific (SMLR), Stereotaxis (STXS) and Cutera (CUTR). What other stocks do shareholders of GETINGE AB/ADR own? Based on aggregate information from My MarketBeat watchlists, some companies that other GETINGE AB/ADR investors own include Immunomedics (IMMU), Oracle (ORCL), Total (FP), FOX (FOXA), Regeneron Pharmaceuticals (REGN), Skyworks Solutions (SWKS), United Continental (UAL), Alteryx (AYX), BP (BP) and Boston Scientific (BSX). Who are GETINGE AB/ADR's key executives? GETINGE AB/ADR's management team includes the following people: Mr. Mattias Perjos M.Sc., CEO, Pres & Director (Age 47)Mr. Lars Sandström M.Sc., Chief Financial Officer (Age 47)Lars Mattson, Head of Investor RelationsMs. Lena Hagman B.Sc., Exec. VP of Quality & Regulatory Compliance (Age 54)Mr. Abraham Ronai, Gen. Counsel What is GETINGE AB/ADR's stock symbol? GETINGE AB/ADR trades on the OTCMKTS under the ticker symbol "GNGBY." How do I buy shares of GETINGE AB/ADR? Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is GETINGE AB/ADR's stock price today? One share of GNGBY stock can currently be purchased for approximately $18.47. How big of a company is GETINGE AB/ADR? GETINGE AB/ADR has a market capitalization of $4.69 billion and generates $2.81 billion in revenue each year. GETINGE AB/ADR employs 12,000 workers across the globe. View additional information about GETINGE AB/ADR. What is GETINGE AB/ADR's official website? The official website for GETINGE AB/ADR is http://www.getinge.com/. How can I contact GETINGE AB/ADR? GETINGE AB/ADR's mailing address is LINDHOLMSPIREN 7, GOTHENBURG V7, 417 56. The company can be reached via phone at 46-1-033-500-00 or via email at [email protected] This page was last updated on 4/8/2020 by MarketBeat.com StaffFeatured Article: Cost of Goods Sold (COGS)
